Sustained improvement of the quality of life of patients with psoriasis after hospitalization

Vensel, Eric; Hilley, Theresa; Trent, Jennifer T.; Kirsner, Robert S.; Kerdel, Francisco A.; Taylor, John R.; Schwartzberg, Jordan B.

doi:10.1067/mjd.2000.106512

Cited by 25 publications

(9 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar findings are described in the relatively few international studies that have been done in this area (8,9,(12)(13)(14)(15). The greatest improvement in QoL is for the group as a whole related to the sub-area symptoms and feelings.…”

Section: Discussionsupporting

confidence: 82%

See 1 more Smart Citation

Changes in Quality of Life in Persons with Eczema and Psoriasis After Treatment in Departments of Dermatology

Wahl¹,

Mørk²,

Lillehol³

et al. 2006

Acta Derm Venereol

View full text Add to dashboard Cite

The objective of this study was to assess the impact of chronic dermatological diseases on quality of life (QoL) of Norwegian patients following in-patient management. QoL was measured by the Norwegian version of the Dermatology Life Quality Index, a validated, self-administered questionnaire. Adult in-patients with psoriasis and eczema were selected for one year from the dermatological departments in Norway. A total of 212 patients were included, and 126 patients (50% men, 85 with psoriasis and 41 with eczema, mean age 46 years) completed the questionnaires at time of hospital admission and one week after discharge. The patients reported adverse impact on QoL, but no differences between the psoriasis and eczema groups could be demonstrated. Patients with psoriasis improved from 18.3 (7.6) (mean (SD)) to 12.1 (8.2) (p < 0.01), and those with eczema improved from 20.0 (6.0) to 14.4 (7.8) (p < 0.01). Seventy percent of the patients showed improvement, 20% remained unchanged and 10% worsened. The parameters for which the most improvement was seen were those that were of most concern to the patients, i.e. their symptoms and embarrassment. In conclusion, the results are consistent with previous international studies.

show abstract

Section: Discussionsupporting

confidence: 82%

“…Until now, few studies have evaluated the change in QoL after hospitalization in patients with eczema and psoriasis. The studies that have been done show positive changes in relation to QoL (8,9). In this article we report the results from the first Norwegian study.…”

Section: Figures From Statistics Norwaymentioning

confidence: 85%

Changes in Quality of Life in Persons with Eczema and Psoriasis After Treatment in Departments of Dermatology

Wahl¹,

Mørk²,

Lillehol³

et al. 2006

Acta Derm Venereol

View full text Add to dashboard Cite

show abstract

“…Importantly, this benefit was sustained for 3 months after discharge. 2 These results were presented and published. 3,4 In addition, Dr Trent studied the efficacy of intravenous immunoglobulin (IVIg) for the treatment of toxic epidermal necrolysis (TEN).…”

supporting

confidence: 82%

American Academy of Dermatology 2004 Awards for Young Investigators in Dermatology

2005

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…All other studies on the effectiveness of hospitalization chose changes in mean scores as outcome [11, 19, 32]. Our study clearly shows that the inference regarding the stability of remission drawn from the whole study population, e.g.…”

Section: Discussionmentioning

confidence: 59%

Effectiveness of Inpatient Treatment on Quality of Life and Clinical Disease Severity in Atopic Dermatitis and Psoriasis Vulgaris – A Prospective Study

et al. 2006

View full text Add to dashboard Cite

Background: Financial constraints challenge evidence of the effectiveness of dermatological inpatient management. Objective: To evaluate the effectiveness of hospitalization in atopic dermatitis and psoriasis regarding initial and sustained benefits. Methods: Prospective study on adults with psoriasis vulgaris (n = 22) and atopic dermatitis (n = 14). At admission, discharge, and 3 months after discharge, validated outcomes of objective and subjective disease severity were assessed by trained investigators. Results: Hospitalization resulted in substantial benefit in quality of life and clinical disease severity. Looking at mean scores, the observed benefit appeared stable until 3-month follow-up. The analysis of individual patient data revealed significant changes in disease severity between discharge and 3-month follow-up with some patients relapsing, others further improving. Reasons for hospitalization and treatment performed were not related to sustained benefit. Conclusions: In psoriasis vulgaris and atopic dermatitis, hospitalization effectively improved quality of life and clinical disease severity. Further research should focus on prognostic factors for sustained improvement.

show abstract

Sustained improvement of the quality of life of patients with psoriasis after hospitalization

Cited by 25 publications

References 12 publications

Changes in Quality of Life in Persons with Eczema and Psoriasis After Treatment in Departments of Dermatology

Changes in Quality of Life in Persons with Eczema and Psoriasis After Treatment in Departments of Dermatology

American Academy of Dermatology 2004 Awards for Young Investigators in Dermatology

Effectiveness of Inpatient Treatment on Quality of Life and Clinical Disease Severity in Atopic Dermatitis and Psoriasis Vulgaris – A Prospective Study

Contact Info

Product

Resources

About